Comparing Brixadi vs Sublocade
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|---|
| Brixadi (buprenorphine) | Sublocade (buprenorphine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Opiate Dependence - Maintenance, Opioid Use Disorder. Brixadi may also be used for purposes not listed in this medication guide. |
Prescription only
Sublocade is a once-monthly injection that may be used to treat adults with opioid use disorder and is administered subcutaneously (under the skin) into the stomach (abdomen), thigh, buttock, or... View more |
Related suggestions Opioid Use Disorder
Opiate Dependence - Maintenance
|
|||||||||||||||
| More about Brixadi (buprenorphine) | More about Sublocade (buprenorphine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Brixadi has an average rating of 6.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sublocade has an average rating of 7.9 out of 10 from a total of 305 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Brixadi side effects |
View all Sublocade side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
|
None |
None |
||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Brixadi prices |
View all Sublocade prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other buprenorphine brands include: Belbuca, Buprenex, Butrans, Sublocade | Other buprenorphine brands include: Belbuca, Brixadi, Buprenex, Butrans | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
48 hours |
48 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 716 drugs are known to interact with Brixadi:
|
A total of 716 drugs are known to interact with Sublocade:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 23, 2023 |
November 30, 2017 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.